Dublin-based Prothena to sell drug to Novo Nordisk in $1.2bn deal
Drugmaker, which spun out of Elan is selling PRX004 so it can focus on other therapies
Shares in Dublin-based Prothena surge as it seeks to raise $67.8m
Nasdaq-listed company was spun out of Irish drugmaker Elan back in 2012
UDG Healthcare appoints two non-executive directors to board
Peter Chambré and Shane Cooke to take up roles with services provider on February 1st
Dublin based biotech Prothena plunges as key drug fails
Elan spin-out plunged 70% after its main drug failed in a crucial clinical trial
Don’t cry over tech selloff – it’s still the top performer
Stocktake: Tech stock fall is factor-led. Plus: Trump’s tax cuts; Weinstein’s ‘comeback’
Up to 50 new biotech jobs to be created in Dublin by Daybreak
Daybreak Information Technologies is the creation of Kevin Barrett, former CIO of Elan
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices